557 related articles for article (PubMed ID: 17540812)
1. Cost-effectiveness analysis of strategies for the surgical management of grade 1 endometrial adenocarcinoma.
Cohn DE; Huh WK; Fowler JM; Straughn JM
Obstet Gynecol; 2007 Jun; 109(6):1388-95. PubMed ID: 17540812
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness analysis of strategies for the surgical management of grade 1 endometrial adenocarcinoma.
Kwon J; Carey M; Goldie S; Kim J
Obstet Gynecol; 2007 Oct; 110(4):933; author reply 933-4. PubMed ID: 17906041
[No Abstract] [Full Text] [Related]
3. Is selective lymphadenectomy more cost-effective than routine lymphadenectomy in patients with endometrial cancer?
Clements AE; Tierney BJ; Cohn DE; Straughn JM
Gynecol Oncol; 2013 Feb; 128(2):166-70. PubMed ID: 23078763
[TBL] [Abstract][Full Text] [Related]
4. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma.
Mohan DS; Samuels MA; Selim MA; Shalodi AD; Ellis RJ; Samuels JR; Yun HJ
Gynecol Oncol; 1998 Aug; 70(2):165-71. PubMed ID: 9740684
[TBL] [Abstract][Full Text] [Related]
6. Pelvic lymphadenectomy as alternative to postoperative radiotherapy in high risk early stage endometrial cancer.
Papanikolaou A; Kalogiannidis I; Goutzioulis M; Misailidou D; Makedos A; Vergote I; Makedos G
Arch Gynecol Obstet; 2006 May; 274(2):91-6. PubMed ID: 16518607
[TBL] [Abstract][Full Text] [Related]
7. The long-term survival of women with surgical stage II endometrioid type endometrial cancer.
Ayhan A; Taskiran C; Celik C; Yuce K
Gynecol Oncol; 2004 Apr; 93(1):9-13. PubMed ID: 15047207
[TBL] [Abstract][Full Text] [Related]
8. Conservative management of stage I endometrial carcinoma after surgical staging.
Straughn JM; Huh WK; Kelly FJ; Leath CA; Kleinberg MJ; Hyde J; Numnum TM; Zhang Y; Soong SJ; Austin JM; Partridge EE; Kilgore LC; Alvarez RD
Gynecol Oncol; 2002 Feb; 84(2):194-200. PubMed ID: 11812074
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of adjuvant radiotherapy in intermediate risk endometrial cancer.
Rankins NC; Secord AA; Jewell E; Havrilesky LJ; Soper JT; Myers E
Gynecol Oncol; 2007 Aug; 106(2):388-93. PubMed ID: 17509672
[TBL] [Abstract][Full Text] [Related]
10. Potential benefit of lymphadenectomy for the treatment of node-negative locally advanced uterine cancers.
Seago DP; Raman A; Lele S
Gynecol Oncol; 2001 Nov; 83(2):282-5. PubMed ID: 11606085
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness analysis of the treatment for intermediate risk endometrial cancer: postoperative brachytherapy vs. observation.
Fanning J; Hoffman ML; Andrews SJ; Harrah AW; Feldmeier JJ
Gynecol Oncol; 2004 Jun; 93(3):632-6. PubMed ID: 15196856
[TBL] [Abstract][Full Text] [Related]
12. Cost effectiveness of a test to detect metastases for endometrial cancer.
Havrilesky LJ; Maxwell GL; Chan JK; Myers ER
Gynecol Oncol; 2009 Mar; 112(3):526-30. PubMed ID: 19100608
[TBL] [Abstract][Full Text] [Related]
13. Surgical staging for patients presenting with grade 1 endometrial carcinoma.
Ben-Shachar I; Pavelka J; Cohn DE; Copeland LJ; Ramirez N; Manolitsas T; Fowler JM
Obstet Gynecol; 2005 Mar; 105(3):487-93. PubMed ID: 15738013
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of treatment of early stage endometrial cancer.
Ashih H; Gustilo-Ashby T; Myers ER; Andrews J; Clarke-Pearson DL; Berry D; Berchuck A
Gynecol Oncol; 1999 Aug; 74(2):208-16. PubMed ID: 10419733
[TBL] [Abstract][Full Text] [Related]
15. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.
Benedetti Panici P; Basile S; Maneschi F; Alberto Lissoni A; Signorelli M; Scambia G; Angioli R; Tateo S; Mangili G; Katsaros D; Garozzo G; Campagnutta E; Donadello N; Greggi S; Melpignano M; Raspagliesi F; Ragni N; Cormio G; Grassi R; Franchi M; Giannarelli D; Fossati R; Torri V; Amoroso M; Crocè C; Mangioni C
J Natl Cancer Inst; 2008 Dec; 100(23):1707-16. PubMed ID: 19033573
[TBL] [Abstract][Full Text] [Related]
16. [The surgical and radiotherapy treatment of endometrial adenocarcinoma. A retrospective analysis of 128 patients].
Sacco M; Rotta P; Rampino M
Radiol Med; 1991 Nov; 82(5):658-63. PubMed ID: 1780466
[TBL] [Abstract][Full Text] [Related]
17. FIGO stage IIIC endometrial carcinoma: prognostic factors and outcomes.
Hoekstra AV; Kim RJ; Small W; Rademaker AW; Helenowski IB; Singh DK; Schink JC; Lurain JR
Gynecol Oncol; 2009 Aug; 114(2):273-8. PubMed ID: 19428094
[TBL] [Abstract][Full Text] [Related]
18. Should selective paraaortic lymphadenectomy be part of surgical staging for endometrial cancer?
Faught W; Krepart GV; Lotocki R; Heywood M
Gynecol Oncol; 1994 Oct; 55(1):51-5. PubMed ID: 7959266
[TBL] [Abstract][Full Text] [Related]
19. Multicenter analysis of recurrence and survival in stage IIIA endometrial cancer.
Havrilesky LJ; Secord AA; O'Malley DM; Broadwater G; Bae-Jump V; Cohn DE; Gehrig PA
Gynecol Oncol; 2009 Aug; 114(2):279-83. PubMed ID: 19446319
[TBL] [Abstract][Full Text] [Related]
20. The impact of complete surgical staging on adjuvant treatment decisions in endometrial cancer.
Goudge C; Bernhard S; Cloven NG; Morris P
Gynecol Oncol; 2004 May; 93(2):536-9. PubMed ID: 15099975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]